人工转录因子的开发及其在细胞重编程,遗传查和疾病治疗中的应用
Yetong Sang1, Lingjie Xu1, Zehua Bao2
1Institute of Bioengineering & Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, Zhejiang, China; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou 311215, Zhejiang, China.
概括
人工转录因子 (ATF) 提供了新的方式来调节与癌症等疾病相关的基因. 交付和耐久性方面的挑战阻碍了它们的治疗用途,但正在出现克服这些障碍的战略.
科学领域:
- 分子生物学分子生物学
- 基因规则 基因规则
- 合成生物学 合成生物学
背景情况:
- 基因失调是人类疾病的关键因素,包括癌症和遗传性疾病.
- 人工转录因子 (ATF) 是设计用于控制疾病相关基因表达的工程分子.
- 在基础研究和生物医学应用,包括疾病治疗方面,ATF具有显著的潜力.
研究的目的:
- 审查人工转录因子 (ATF) 的功能组件和应用.
- 突出阻碍ATF临床转化所面临的挑战.
- 建议策略,以提高治疗用途的ATF的有效性和耐用性.
主要方法:
- 关于人工转录因子 (ATF) 设计和工程的文献综述.
- 对ATF功能组件的分析:DNA结合域,转录效应器域和控制开关.
- 检查ATF在细胞重编程,分化,致病基因查和疾病治疗中的应用.
主要成果:
- ATF已经在各种应用中证明了其实用性,包括细胞操纵和疾病建模.
- 对于ATF的临床转化,仍然存在重大障碍,包括免疫性,分娩,非目标效应和缺乏持久的基因激活.
- 确定了改进ATF分子工具的潜在策略.
结论:
- 人工转录因子 (ATF) 是一种有前途的分子工具,用于疾病环境中的基因调节.
- 克服目前免疫性,输送,特异性和耐久性的局限性对于推动ATF向临床应用至关重要.
- 需要进一步的研究和战略开发,才能充分实现ATF的治疗潜力.
相关概念视频
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Combinatorial Gene Control
8.3K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.3K
Transcription Factors
75.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.7K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K


